Diagnostic evaluation of 2', 5'-oligoadenylate synthetase activities and antibodies against Epstein-Barr virus and Coxiella burnetii in patients with chronic fatigue syndrome in Japan. — CFSMEATLAS
Diagnostic evaluation of 2', 5'-oligoadenylate synthetase activities and antibodies against Epstein-Barr virus and Coxiella burnetii in patients with chronic fatigue syndrome in Japan.
Ikuta, Kazufumi, Yamada, Takeshi, Shimomura, Tokio et al. · Microbes and infection · 2003 · DOI
Quick Summary
This study tested whether certain viral infections and immune system markers are linked to ME/CFS. Researchers measured a protein called 2-5AS in blood cells from ME/CFS patients in Japan and compared it to healthy people. They found that ME/CFS patients had higher levels of this immune marker than healthy controls, and some patients showed signs of past infections with Epstein-Barr virus or another bacteria.
Why It Matters
This research provides potential laboratory markers (2-5AS activity) that could aid in diagnosing ME/CFS and suggests viral infections may play a role in disease pathogenesis. Understanding immune dysregulation associated with viral reactivation could inform future therapeutic targets.
Observed Findings
2-5AS activity was detected in 86% of patients at Hospital H1 and 32% at Hospital H2, compared to 11% of healthy controls
EBV anti-EA-IgG antibodies were found in 9% of H1 patients and 32% of H2 patients
C. burnetii antibodies were detected in 27% of H1 patients but 0% of H2 patients
Statistical correlation existed between 2-5AS activities and EBV anti-EA-IgG titers (P<0.05)
No significant correlation was found between 2-5AS activities and C. burnetii antibody titers
Inferred Conclusions
Some ME/CFS patients show evidence of immune dysregulation (elevated 2-5AS) that may be associated with viral infections
2-5AS activity may serve as a useful diagnostic marker for ME/CFS
Epstein-Barr virus appears more directly linked to immune abnormalities than C. burnetii based on correlation analyses
Geographic or hospital-specific factors influence the prevalence of these markers in ME/CFS populations
Remaining Questions
Why did 2-5AS detection rates differ so dramatically between the two hospitals (86% vs 32%) if both studied ME/CFS patients?
What This Study Does Not Prove
This study does not prove that EBV or C. burnetii cause ME/CFS—it only shows associations in some patients. The wide variation between the two hospitals (86% vs 32% 2-5AS detection in patients) raises questions about whether results reflect true biological differences or methodological variation. Elevated 2-5AS may be a consequence rather than a cause of ME/CFS.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →